The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer

Health Economics

Volumn 18, Issue 12, 2009, Pages 1381-1393

  Howard, David H ^a   Tangka, Florence K ^b   Seeff, Laura C ^b   Richardson, Lisa C ^b   Ekwueme, Donatus U ^b  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cancer screening; Colorectal cancer; Cost analysis; Preventive medicine

Indexed keywords

CAPECITABINE; IRINOTECAN; OXALIPLATIN;

ARTICLE; CALCULATION; CANCER CHEMOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MEDICARE; POLYP; POLYPECTOMY; PRECANCER; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COSTS AND COST ANALYSIS; FEMALE; HEALTH EXPENDITURES; HUMANS; MALE; MASS SCREENING; POLYPS; PRECANCEROUS CONDITIONS; PREVENTIVE MEDICINE;

EID: 73349107445     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1434     Document Type: Article

References (19)

1. AHRQ Clinical Classifications Software (CCS) for ICD-9-CM. 2006. Available from: http://www.hcupus. ahrq.gov/toolssoftware/ccs/ccs.jsp#overview. Accessed: October 2, 2006.
2. Arias E. 2001. United States life tables. National Vital Statistics Reports, vol. 52(14), National Center for Health Statistics, Hyattsville, MD.
3. Brown ML, Riley GF, Schussler N, Etzioni RD. 2002. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical Care 40(8 Suppl): IV-104-17.
4. Cooper GS, Payes JD. 2005. Receipt of colorectal testing prior to colorectal carcinoma diagnosis. Cancer 103: 696-701.
5. Etzioni R, Ramsey SD, Berry K et al. 2001. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study. Health Economics 10: 245-256.
6. Harper PR, Jones SK. 2005. Mathematical models for the early detection and treatment of colorectal cancer. Health Care Management Science 8: 101-109.
7. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. 2002. Results of screening colonoscopy among persons 40 to 49 years of age. New England Journal of Medicine 346(23): 1781-1785.
8. Lieberman DA, Weiss DG. 2001. Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. New England Journal of Medicine 345(8): 555-560.
9. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. 2000. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. New England Journal of Medicine 343(3): 162-168.
10. Lin OS, Kozarek RA, Schembre DB et al. 2006. Screening colonoscopy in very elderly patients. Journal of the American Medical Association 295: 2357-2365.
11. Loeve F, Boer R, van Oortmarssen GJ et al. 1999. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Computers and Biomedical Research 32: 13-33.
12. Mennemeyer ST, Cyr LP. 1997. A bootstrap approach to medical decision analysis. Journal of Health Economics 16(6): 741-747.
13. Pabby A, Schoen S, Weissfeld J, Burt R, Kikendall J, Lance P, Shike M, Lanza E, Schatzkin A. 2005. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointestinal Endoscopy 61(3): 385-391.
14. Pignone M, Saha S, Hoerger T et al. 2002. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 137: 96-104.
15. Polsky D, Glick HA, Willke R, Schulman K. 1997. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Economics 6(3): 243-252.
16. Ramsey SD, Mandelson MT, Berry K et al. 2003. Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology 125: 1645-1650.
17. Schrag D. 2004. The price tag on progress - chemotherapy for colorectal cancer. New England Journal of Medicine 351: 317-319.
18. Seef LC, Shapiro JA, Nadel MR. 2002. Are we doing enough to screen for colorectal cancer? Findings from the 1999 behavioral risk factor surveillance system. Journal of Family Practice 51: 761-766.
19. Whynes DK, Walker AR, Hardcastle JD. 1992. Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas. Health Economics 1: 53-60.